Who Paid My Doc
Michael Ison
Infectious Disease Falls Church, VA Medical Doctor
NPI 1316941222 CMS profile 332075
3300 Gallows Rd, Falls Church, VA 22042
General payments
$87,958
Research payments
$14,920
Ownership & investment interest
$0
Research they led as principal investigator
$231,714
Through program year 2025, Michael Ison of Falls Church, VA is reported in the CMS Open Payments database as having received $87,958 across 61 general payments and $14,920 in research payments paid to them. Separately, studies naming them as principal investigator received $231,714 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 96th percentile of Infectious Disease profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
9 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $14 | 1 | |
| 2023 | General | $1,080 | 1 | |
| 2022 | General | $34,403 | 22 | |
| 2022 | Research | $5,750 | 4 | |
| 2021 | General | $12,352 | 11 | |
| 2021 | Research | $1,925 | 4 | |
| 2020 | General | $24,439 | 18 | |
| 2020 | Research | $7,245 | 8 | |
| 2019 | General | $15,671 | 8 |
Beside peers
- Michael Ison
- Infectious Disease median
- Middle half of Infectious Disease
- National median
In program year 2025, general payments to Michael Ison were reported at $14. Among 3,905 Infectious Disease profiles paid that year, the median was $188 and the middle half received between $57 and $766.
Show as a table
| Year | Michael Ison | Infectious Disease median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $15,671 | $190 | $60–$862 | $163 |
| 2020 | $24,439 | $124 | $32–$606 | $114 |
| 2021 | $12,352 | $148 | $38–$905 | $132 |
| 2022 | $34,403 | $166 | $50–$834 | $149 |
| 2023 | $1,080 | $171 | $57–$787 | $160 |
| 2024 | $0 | $176 | $52–$752 | $164 |
| 2025 | $14 | $188 | $57–$766 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
77 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Infectious Disease in Virginia
Christopher Bettacchi
Infectious Disease · Marion, VA
Stephen Weinroth
Infectious Disease · Fairfax, VA
William Petri
Infectious Disease · Charlottesville, VA
Valerie Riddle
Infectious Disease · Bumpass, VA
Edward Oldfield
Infectious Disease · Norfolk, VA
William Furlong
Infectious Disease · Arlington, VA
Related records
Infectious Disease in Virginia
Practitioners in the same specialty and state, ranked by reported value.
All Infectious Disease
Everyone recorded under this specialty, nationwide.
Doctors in Virginia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.